Yan Gao

8PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCellular immunologyGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 21, 2026
Combination of mitoxantrone hydrochloride liposome with cyclophosphamide, vincristine, and prednisone for patients with treatment-naive peripheral T-cell lymphoma: A multicenter, open-label, single-arm, phase 1b trial.

Yan Gao, Ming Jiang, Xuanye Zhang

|Oct 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma.

Cheng Huang, Yan Gao, Jianfeng Chen

|Feb 06, 2025
High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study.

Yan Gao, Liqin Ping, Changguo Shan

|Jan 03, 2025
Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial.

Yan Gao, Yunhong Huang, Qingyuan Zhang

|Dec 29, 2022
Immunogenic Cell Death (ICD)-Related Gene Signature Could Predict the Prognosis of Patients with Diffuse Large B-Cell Lymphoma.

Liqin Ping, Yanxia He, Yan Gao

|Oct 27, 2022
Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia.

Yan Gao, Jia-Fan Zhou, Jia-Ying Mao

Pageof 2

Frequent Collaborators

3 joint publications

Huiqiang Huang

2 joint publications

Cheng Huang

1 joint publications

Panpan Liu

1 joint publications

Xue-Ping Li